Impact of weight loss on plasma leptin and adiponectin in overweight-to-obese post menopausal breast cancer survivors

Nutrients

Volumn 7, Issue 7, 2015, Pages 5156-5176

  Thompson, Henry J ^a   Sedlacek, Scot M ^a,b   Wolfe, Pamela ^c   Paul, Devchand ^b   Lakoski, Susan G ^d   Playdon, Mary C ^a,e   McGinley, John N ^a   Matthews, Shawna B ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b ROCKY MOUNTAIN CANCER CENTERS   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

Adiponectin; Body composition; Breast cancer survivors; Dietary pattern; Leptin; Weight loss

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVOR; CONTROLLED STUDY; FAT MASS; FEMALE; HIP CIRCUMFERENCE; HUMAN; LOW CARBOHYDRATE DIET; LOW FAT DIET; OBESITY; POSTMENOPAUSE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; BLOOD; BREAST TUMOR; COMPLICATION; DIET THERAPY; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; SURVIVOR; TIME FACTOR;

ADIPONECTIN; ANTHROPOMETRY; BIOMARKERS; BODY MASS INDEX; BREAST NEOPLASMS; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; OVERWEIGHT; POSTMENOPAUSE; PROGNOSIS; SURVIVORS; TIME FACTORS; WEIGHT LOSS;

EID: 84936863972     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7075156     Document Type: Article

References (76)

1. Ewertz, M.; Jensen, M.B.; Gunnarsdottir, K.A.; Hojris, I.; Jakobsen, E.H.; Nielsen, D.; Stenbygaard, L.E.; Tange, U.B.; Cold, S. Effect of obesity on prognosis after early-stage breast cancer. J. Clin. Oncol. 2011, 29, 25–31.
2. Demark-Wahnefried, W.; Platz, E.A.; Ligibel, J.A.; Blair, C.K.; Courneya, K.S.; Meyerhardt, J.A.; Ganz, P.A.; Rock, C.L.; Schmitz, K.H.; Wadden, T.; et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol. Biomarkers Prev. 2012, 21, 1244–1259.
3. Protani, M.; Coory, M.; Martin, J.H. Effect of obesity on survival of women with breast cancer: Systematic review and meta-analysis. Breast Cancer Res. Treat. 2010, 123, 627–635.
4. Al-Delaimy, W.K.; Flatt, S.W.; Natarajan, L.; Laughlin, G.A.; Rock, C.L.; Gold, E.B.; Caan, B.J.; Parker, B.A.; Pierce, J.P. IGF1 and risk of additional breast cancer in the WHEL study. Endocr. Relat. Cancer 2011, 18, 235–244.
5. Oh, S.W.; Park, C.Y.; Lee, E.S.; Yoon, Y.S.; Lee, E.S.; Park, S.S.; Kim, Y.; Sung, N.J.; Yun, Y.H.; Lee, K.S.; et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: A cohort study. Breast Cancer Res. 2011, 13, R34.
6. Goodwin, P.J.; Ennis, M.; Pritchard, K.I.; Trudeau, M.E.; Koo, J.; Taylor, S.K.; Hood, N. Insulin- and obesity-related variables in early-stage breast cancer: Correlations and time course of prognostic associations. J. Clin. Oncol. 2012, 30, 164–171.
7. Macis, D.; Gandini, S.; Guerrieri-Gonzaga, A.; Johansson, H.; Magni, P.; Ruscica, M.; Lazzeroni, M.; Serrano, D.; Cazzaniga, M.; Mora, S.; et al. Prognostic effect of circulating adiponectin in a randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J. Clin. Oncol. 2012, 30, 151–157.
8. Cho, Y.A.; Sung, M.K.; Yeon, J.Y.; Ro, J.; Kim, J. Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res. Treat. 2013, 45, 210–219.
9. Wadden, T.A.; Butryn, M.L.; Wilson, C. Lifestyle modification for the management of obesity. Gastroenterology 2007, 132, 2226–2238.
10. Foster-Schubert, K.E.; Alfano, C.M.; Duggan, C.R.; Xiao, L.; Campbell, K.L.; Kong, A.; Bain, C.E.; Wang, C.Y.; Blackburn, G.L.; McTiernan, A. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity 2012, 20, 1628–1638.
11. Thomson, C.A.; Thompson, P.A. Dietary patterns, risk and prognosis of breast cancer. Future Oncol. 2009, 5, 1257–1269.
12. Gold, E.B.; Pierce, J.P.; Natarajan, L.; Stefanick, M.L.; Laughlin, G.A.; Caan, B.J.; Flatt, S.W.; Emond, J.A.; Saquib, N.; Madlensky, L.; et al. Dietary pattern influences breast cancer prognosis in women without hot flashes: The women’s healthy eating and living trial. J. Clin. Oncol. 2009, 27, 352–359.
13. Prentice, R.L.; Anderson, G.L. The women’s health initiative: Lessons learned. Annu. Rev. Public Health 2008, 29, 131–150.
14. Prentice, R.L. Observational studies, clinical trials, and the women’s health initiative. Lifetime Data Anal. 2007, 13, 449–462.
15. Pierce, J.P.; Faerber, S.; Wright, F.A.; Rock, C.L.; Newman, V.; Flatt, S.W.; Kealey, S.; Jones, V.E.; Caan, B.J.; Gold, E.B.; et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: The Women’s Healthy Eating and Living (WHEL) Study. Control Clin. Trials 2002, 23, 728–756.
16. Ho, V.W.; Hamilton, M.J.; Dang, N.H.; Hsu, B.E.; Adomat, H.H.; Guns, E.S.; Weljie, A.; Samudio, I.; Bennewith, K.L.; Krystal, G. A low carbohydrate, high protein diet combined with celecoxib markedly reduces metastasis. Carcinogenesis 2014, 35, 2291–2299.
17. Liebman, M. When and why carbohydrate restriction can be a viable option. Nutrition 2014, 30, 748–754.
18. Huebner, J.; Marienfeld, S.; Abbenhardt, C.; Ulrich, C.; Muenstedt, K.; Micke, O.; Muecke, R.; Loeser, C. Counseling patients on cancer diets: A review of the literature and recommendations for clinical practice. Anticancer Res. 2014, 34, 39–48.
19. Paoli, A.; Rubini, A.; Volek, J.S.; Grimaldi, K.A. Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur. J. Clin. Nutr. 2013, 67, 789–796.
20. Nilsson, L.M.; Winkvist, A.; Johansson, I.; Lindahl, B.; Hallmans, G.; Lenner, P.; Van, G.B. Low-carbohydrate, high-protein diet score and risk of incident cancer; a prospective cohort study. Nutr. J. 2013, 12, 58.
21. Busetto, L.; Marangon, M.; De, S.F. High-protein low-carbohydrate diets: What is the rationale? Diabetes Metab. Res. Rev. 2011, 27, 230–232.
22. Thomson, C.A.; Stopeck, A.T.; Bea, J.W.; Cussler, E.; Nardi, E.; Frey, G.; Thompson, P.A. Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets. Nutr. Cancer 2010, 62, 1142–1152.
23. Boeke, C.E.; Eliassen, A.H.; Chen, W.Y.; Cho, E.; Holmes, M.D.; Rosner, B.; Willett, W.C.; Tamimi, R.M. Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies. Breast Cancer Res. Treat. 2014, 146, 383–392.
24. Michels, K.B.; Willett, W.C. The women’s health initiative randomized controlled dietary modification trial: A post-mortem. Breast Cancer Res. Treat. 2009, 114, 1–6.
25. Bilsborough, S.A.; Crowe, T.C. Low-carbohydrate diets: What are the potential short- and long-term health implications? Asia Pac. J. Clin. Nutr. 2003, 12, 396–404.
26. McTiernan, A. Obesity and cancer: The risks, science, and potential management strategies. Oncology 2005, 19, 871–881.
27. Chen, X.; Wang, Y. Adiponectin and breast cancer. Med. Oncol. 2011, 28, 1288–1295.
28. Garofalo, C.; Koda, M.; Cascio, S.; Sulkowska, M.; Kanczuga-Koda, L.; Golaszewska, J.; Russo, A.; Sulkowski, S.; Surmacz, E. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli. Clin. Cancer Res. 2006, 12, 1447–1453.
29. Gaudet, M.M.; Falk, R.T.; Gierach, G.L.; Lacey, J.V., Jr.; Graubard, B.I.; Dorgan, J.F.; Brinton, L.A. Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol. 2010, 34, 580–586.
30. Grossmann, M.E.; Ray, A.; Nkhata, K.J.; Malakhov, D.A.; Rogozina, O.P.; Dogan, S.; Cleary, M.P. Obesity and breast cancer: Status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010, 29, 641–653.
31. Grossmann, M.E.; Cleary, M.P. The balance between leptin and adiponectin in the control of carcinogenesis—Focus on mammary tumorigenesis. Biochimie 2012, 94, 2164–2171.
32. Havel, P.J. Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 2002, 13, 51–59.
33. Rose, D.P.; Komninou, D.; Stephenson, G.D. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 2004, 5, 153–165.
34. Forsblom, C.; Thomas, M.C.; Moran, J.; Saraheimo, M.; Thorn, L.; Waden, J.; Gordin, D.; Frystyk, J.; Flyvbjerg, A.; Groop, P.H. Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J. Intern. Med. 2011, 270, 346–355.
35. Trujillo, M.E.; Scherer, P.E. Adiponectin—Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 2005, 257, 167–175.
36. Gautron, L.; Elmquist, J.K. Sixteen years and counting: An update on leptin in energy balance. J. Clin. Investig. 2011, 121, 2087–2093.
37. Harwood, H.J., Jr. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2012, 63, 57–75.
38. Sedlacek, S.M.; Playdon, M.C.; Wolfe, P.; McGinley, J.N.; Wisthoff, M.R.; Daeninck, E.A.; Jiang, W.; Zhu, Z.; Thompson, H.J. Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients (“CHOICE”): Study protocol. BMC Cancer 2011, 11, 287.
39. Abbenhardt, C.; McTiernan, A.; Alfano, C.M.; Wener, M.H.; Campbell, K.L.; Duggan, C.; Foster-Schubert, K.E.; Kong, A.; Toriola, A.T.; Potter, J.D.; et al. Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J. Intern. Med. 2013, 274, 163–175.
40. Fabian, C.J.; Kimler, B.F.; Donnelly, J.E.; Sullivan, D.K.; Klemp, J.R.; Petroff, B.K.; Phillips, T.A.; Metheny, T.; Aversman, S.; Yeh, H.W.; et al. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10% weight loss in postmenopausal women. Breast Cancer Res. Treat. 2013, 142, 119–132.
41. Considine, R.V.; Sinha, M.K.; Heiman, M.L.; Kriauciunas, A.; Stephens, T.W.; Nyce, M.R.; Ohannesian, J.P.; Marco, C.C.; McKee, L.J.; Bauer, T.L. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996, 334, 292–295.
42. Swarbrick, M.M.; Havel, P.J. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab. Syndr. Relat. Disord. 2008, 6, 87–102.
43. Harris, H.R.; Tworoger, S.S.; Hankinson, S.E.; Rosner, B.A.; Michels, K.B. Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev. Res. 2011, 4, 1449–1456.
44. Tian, Y.F.; Chu, C.H.; Wu, M.H.; Chang, C.L.; Yang, T.; Chou, Y.C.; Hsu, G.C.; Yu, C.P.; Yu, J.C.; Sun, C.A. Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr. Relat. Cancer 2007, 14, 669–677.
45. Tworoger, S.S.; Eliassen, A.H.; Kelesidis, T.; Colditz, G.A.; Willett, W.C.; Mantzoros, C.S.; Hankinson, S.E. Plasma adiponectin concentrations and risk of incident breast cancer. J. Clin. Endocrinol. Metab. 2007, 92, 1510–1516.
46. Woo, H.Y.; Park, H.; Ki, C.S.; Park, Y.L.; Bae, W.G. Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett. 2006, 237, 137–142.
47. Wu, M.H.; Chou, Y.C.; Chou, W.Y.; Hsu, G.C.; Chu, C.H.; Yu, C.P.; Yu, J.C.; Sun, C.A. Circulating levels of leptin, adiposity and breast cancer risk. Br. J. Cancer 2009, 100, 578–582.
48. Ye, J.; Jia, J.; Dong, S.; Zhang, C.; Yu, S.; Li, L.; Mao, C.; Wang, D.; Chen, J.; Yuan, G. Circulating adiponectin levels and the risk of breast cancer: A meta-analysis. Eur. J. Cancer Prev. 2014, 23, 158–165.
49. Llanos, A.A.; Krok, J.L.; Peng, J.; Pennell, M.L.; Olivo-Marston, S.; Vitolins, M.Z.; Degraffinreid, C.R.; Paskett, E.D. Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: A randomized trial. Springerplus 2014, 3, 175.
50. Rock, C.L.; Pande, C.; Flatt, S.W.; Ying, C.; Pakiz, B.; Parker, B.A.; Williams, K.; Bardwell, W.A.; Heath, D.D.; Nichols, J.F. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese. Clin. Breast Cancer 2013, 13, 188–195.
51. Sun, K.; Kusminski, C.M.; Scherer, P.E. Adipose tissue remodeling and obesity. J. Clin. Investig. 2011, 121, 2094–2101.
52. Viguerie, N.; Vidal, H.; Arner, P.; Holst, C.; Verdich, C.; Avizou, S.; Astrup, A.; Saris, W.H.; Macdonald, I.A.; Klimcakova, E.; et al. Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 2005, 48, 123–131.
53. Beasley, J.M.; Ange, B.A.; Anderson, C.A.; Miller, E.R., III; Erlinger, T.P.; Holbrook, J.T.; Sacks, F.M.; Appel, L.J. Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: Results from the Optimal Macronutrient Intake Trial to Prevent Heart Disease. Am. J. Epidemiol. 2009, 169, 893–900.
54. Bluher, M.; Rudich, A.; Kloting, N.; Golan, R.; Henkin, Y.; Rubin, E.; Schwarzfuchs, D.; Gepner, Y.; Stampfer, M.J.; Fiedler, M.; et al. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012, 35, 342–349.
55. Ebbeling, C.B.; Swain, J.F.; Feldman, H.A.; Wong, W.W.; Hachey, D.L.; Garcia-Lago, E.; Ludwig, D.S. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA 2012, 307, 2627–2634.
56. Esposito, K.; Di, P.C.; Maiorino, M.I.; Petrizzo, M.; Bellastella, G.; Siniscalchi, I.; Giugliano, D. Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight men. Cardiol. Res. Pract. 2011, 2011, 293916.
57. Ganji, V.; Kafai, M.R.; McCarthy, E. Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population. Nutr. Metab. 2009, 6, 3.
58. Hatami, Z.Z.; Salehi, M.; Heydari, S.T.; Babajafari, S. The effects of 6 isocaloric meals on body weight, lipid profiles, leptin, and adiponectin in overweight subjects (BMI > 25). Int. Cardiovasc. Res. J. 2014, 8, 52–56.
59. Jacobs, D.R., Jr.; Sluik, D.; Rokling-Andersen, M.H.; Anderssen, S.A.; Drevon, C.A. Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: Results from the 1-y randomized Oslo Diet and Exercise Study. Am. J. Clin. Nutr. 2009, 89, 509–517.
60. Jafari-Vayghan, H.; Tarighat-Esfanjani, A.; Jafarabadi, M.A.; Ebrahimi-Mameghani, M.; Ghadimi, S.S.; Lalezadeh, Z. Association between dietary patterns and serum leptin-to-adiponectin ratio in apparently healthy adults. J. Am. Coll. Nutr. 2015, 34, 49–55.
61. Saneei, P.; Hashemipour, M.; Kelishadi, R.; Esmaillzadeh, A. The Dietary Approaches to Stop Hypertension (DASH) diet affects inflammation in childhood metabolic syndrome: A randomized cross-over clinical trial. Ann. Nutr. Metab. 2014, 64, 20–27.
62. Schoeller, D.A.; Buchholz, A.C. Energetics of obesity and weight control: Does diet composition matter? J. Am. Diet. Assoc. 2005, 105, 24–28.
63. Sofer, S.; Eliraz, A.; Kaplan, S.; Voet, H.; Fink, G.; Kima, T.; Madar, Z. Changes in daily leptin, ghrelin and adiponectin profiles following a diet with carbohydrates eaten at dinner in obese subjects. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 744–750.
64. Friedman, J.M.; Mantzoros, C.S. 20 years of leptin: From the discovery of the leptin gene to leptin in our therapeutic armamentarium. Metabolism 2015, 64, 1–4.
65. Newman, G.; Gonzalez-Perez, R.R. LeptinGÇôcytokine crosstalk in breast cancer. Mol. Cell. Endocrinol. 2014, 382, 570–582.
66. Khan, S.; Shukla, S.; Sinha, S.; Meeran, S.M. Role of adipokines and cytokines in obesity-associated breast cancer: Therapeutic targets. Cytokine Growth Factor Rev. 2013, 24, 503–513.
67. Revillion, F.; Charlier, M.; Lhotellier, V.; Hornez, L.; Giard, S.; Baranzelli, M.C.; Djiane, J.; Peyrat, J.P. Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin. Cancer Res. 2006, 12, 2088–2094.
68. Fargnoli, J.L.; Fung, T.T.; Olenczuk, D.M.; Chamberland, J.P.; Hu, F.B.; Mantzoros, C.S. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses’ Health Study. Am. J. Clin. Nutr. 2008, 88, 1213–1224.
69. Yannakoulia, M.; Yiannakouris, N.; Melistas, L.; Kontogianni, M.D.; Malagaris, I.; Mantzoros, C.S. A dietary pattern characterized by high consumption of whole-grain cereals and low-fat dairy products and low consumption of refined cereals is positively associated with plasma adiponectin levels in healthy women. Metabolism 2008, 57, 824–830.
70. Mantzoros, C.S.; Williams, C.J.; Manson, J.E.; Meigs, J.B.; Hu, F.B. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am. J. Clin. Nutr. 2006, 84, 328–335.
71. Heidemann, C.; Hoffmann, K.; Spranger, J.; Klipstein-Grobusch, K.; Mohlig, M.; Pfeiffer, A.F.; Boeing, H. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam Study cohort. Diabetologia 2005, 48, 1126–1134.
72. Van Saun, M.N. Molecular pathways: Adiponectin and leptin signaling in cancer. Clin. Cancer Res. 2013, 19, 1926–1932.
73. Kizer, J.R.; Benkeser, D.; Arnold, A.M.; Mukamal, K.J.; Ix, J.H.; Zieman, S.J.; Siscovick, D.S.; Tracy, R.P.; Mantzoros, C.S.; Defilippi, C.R.; et al. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: The Cardiovascular Health Study. Circulation 2012, 126, 2951–2961.
74. Duggan, C.; Irwin, M.L.; Xiao, L.; Henderson, K.D.; Smith, A.W.; Baumgartner, R.N.; Baumgartner, K.B.; Bernstein, L.; Ballard-Barbash, R.; McTiernan, A. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J. Clin. Oncol. 2011, 29, 32–39.
75. Cleary, M.P.; Ray, A.; Rogozina, O.P.; Dogan, S.; Grossmann, M.E. Targeting the adiponectin: Leptin ratio for postmenopausal breast cancer prevention. Front. Biosci. 2009, 1, 329–357.
76. Satija, A.; Yu, E.; Willett, W.C.; Hu, F.B. Understanding nutritional epidemiology and its role in policy. Adv. Nutr. 2015, 6, 5–18.